What's new in psoriasis treatment? An analysis of systematic reviews published in 2015
Author:
Affiliation:
1. The Dermatology Centre; NIHR Manchester Biomedical Research Centre; Manchester UK
2. Centre of Evidence Based Dermatology; University of Nottingham; Nottingham UK
Publisher
Wiley
Subject
Dermatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ced.13601/fullpdf
Reference37 articles.
1. Evidence-based adverse effects of biologic agents in the treatment of moderate-to-severe psoriasis: providing clarity to an opaque topic;Sorenson;J Dermatolog Treat,2015
2. The British Association of Dermatologists’ Biologic Interventions Register (BADBIR): design, methodology and objectives;Burden;Br J Dermatol,2012
3. Subcutaneous biological treatments for moderate to severe psoriasis: interpreting safety data by network meta-analysis;Messori;Drugs Real World Outcomes,2015
4. Efficacy and safety of secukinumab in the treatment of moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials;Xiong;Int J Clin Exp Med,2015
5. Biosimilars: a systematic review of published and ongoing clinical trials of antipsoriatics in chronic inflammatory diseases;Nast;J Dtsch Dermatol Ges,2015
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non-neoplastic Lesions of the Vulva (Inflammations, Dermatologic Conditions, Infections), Pathology of the Vulva;Encyclopedia of Pathology;2023
2. Non-Neoplastic Lesions of the Vulva (Inflammations, Dermatologic Conditions, Infections), Pathology of the Vulva;Encyclopedia of Pathology;2023
3. Visualising the past to plan the future: a network analysis of the largest European dermatology conference;European Journal of Dermatology;2021-04
4. A network analysis of the EADV 2019 conference;Journal of the European Academy of Dermatology and Venereology;2020-06-30
5. Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis;Expert Review of Clinical Immunology;2020-01-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3